VIVXF News and Press, Avivagen From 11/25/20

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, the...

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, the...

Four tonne order is the largest one-time purchase in Avivagen’s history, and follows UNAHCO’s three tonne order in April of this year, a previous record order. Order comprised of two separate two tonne shipments that demonstrate UNAHCO’s expanded use of ...

Introductory purchase orders secured with Forrajes Tesistan and Prolea Membership in ANFACA and AMEPA to provide extended access to feed mills and farms throughout Mexico Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporatio...

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”),a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and p...

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby s...

Significant increase in revenue driven by significant new and existing customer orders Achieved product sales volume in Q3 equal to 85% of entire 2019 fiscal year volume Customers’ purchasing patterns confirm a recurring revenue business model Avivagen Inc. (TSX...

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / Avivagen: (TSXV:VIV)(OTCQB:VIVXF), a life sciences company with a natural, approved and patented alternative to antibiotics, today announced that it will be presenting at the LD 500 investor conference on Thursday, September 3 rd at 12:40 P...

Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhance and support immune function, thereby supporting general health and perfor...